Vaccine manufacturer
news briefing
(updated September 22, 2025)

South Africa — Biovac (WHO mRNA hub) Sept 2025 — The Biovac Institute (South Africa) is scaling mRNA manufacturing capacity as a core partner of WHO’s mRNA Technology Transfer Programme, with roles spanning technology transfer from Afrigen and GMP-grade scale-up for clinical and later commercial supply aimed at pandemic preparedness. Senegal — Institut Pasteur de Dakar (IPD) Sept 2025 — Institut Pasteur de Dakar is building the MADIBA vaccine facility to supply Africa with multiple vaccines (including yellow fever and outbreak response products), targeting up to 300M doses annually once fully operational. India — Serum Institute of India (SII) Sept 2025 — Serum Institute of India has broadened supply partnerships affecting Africa (including shipment of the R21 malaria vaccine) and continues to develop mRNA and recombinant platforms alongside routine vaccine markets (penta, polio, measles) served via UNICEF/Gavi. ID-EA. India — Bharat Biotech &amp GSK (RTS,S / Mosquirix) Sept 2025 — GSK and Bharat Biotech have committed...